Expression and clinical significance of STAT3, P-STAT3, and VEGF-C in small cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2873-2877

  Zhao, Xue ^a   Sun, Xian ^a   Li, Xiao Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

P STAT3; SCLC; STAT3; Survival; VEGF C

Indexed keywords

EID: 84874100246     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2873     Document Type: Article

References (23)

1. Al Zaid Siddiquee K, Turkson J (2008). STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res, 18, 254-67.
2. Bai LZ, Jiang ZL, Piao W, Wang L, Liu CQ (2005). Vascular endothelial growth factor C expression in lung cancer. Phys Educ Mag, 28, 21-3.
3. Barbieri I, Pensa S, Pannellini T, et al (2010). Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten. Cancer Res, 70, 2558-67.
4. Bromberg J (2002). Stat proteins and oncogenesis. J Clin Invest, 109, 1139-42.
5. Felip E, Pavlidis N, Stahel RA (2005). ESMO m in imum clinical recomm endations for diagnos is, treatment and follow-up of small-cell lung cancer (SCLC). Ann Oncol, 16, 30-1.
6. Fu XY, Schindler C, Improta T, Aebersold R, Darnell JE Jr (1992). The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Nat Acad Sci USA, 89, 7840-3.
7. Garcia R, Bowman TL, Niu G, et al (2001). Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene, 20, 2499-513.
8. Govindan R, Page N, Morgensztern D, et al (2006). C hanging epidemio logy of small cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24, 4539-44.
9. Huang B, Zhou HL, Yang CL (2008). STAT3 gene siRNA carrier construction and its influence to small cell lung cancer. Shandong Med J, 48, 24-6.
10. Joukov V, Pajusola K, Kaipainen A, et al (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VGEFR-3) and KDR (VGEFR-2) receptor tyrosine kinases. EMBO J, 15, 290-8.
11. Li GH, Wei H, Lv SQ, Ji H, Wang DL (2010). Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Int J Oncol, 37, 103-110.
12. Li XL, Wang X, Zhou JH, Zhang AL (2011). STAT3 and MMP-2 expression in cervical carcinoma and its significance. Med J Qilu, 26, 298-300.
13. Liu J, Feng XQ, Wang JH (2011). STAT3 signaling pathway and tumor molecular targeted cancer therapy progress. Chin J Nervous Mental Dis, 37, 442-5.
14. Niu G, Wright KL, Huang M, et al (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene, 21, 2000-8.
15. Ran FM, Wei WL, Hu HY (2011). Research progress of the STAT3 signaling pathway and malignant tumor invasion and metastasis, and treatment. Chin J Lung Cancer, 17, 844-7.
16. Song L, Turkson J, Karras JG, Jove R, Haura EB (2003). Activation of STAT-3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene, 22, 4150-65.
17. Wang M, Chen GY, Song HT (2011). Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer. Experimental Therapeutic Med, 2, 517-522.
18. Xie TX, Huang FJ, Aldape KD, et al (2006). Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res, 66, 3188-96.
19. Xie TX, Wei D, Liu M, et al (2004). Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene, 23, 3550-60.
20. Xu Q, Briggs J, Park S, et al (2005). Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene, 25, 5552-60.
21. Xu WC, Luo CL, Feng WL, Lin X (2003). Expression and clinical significance of signal transducers and activators of transcriptions 3 in non small cell lung cancers. Chin J Clin Lab Sci, 21, 23-4.
22. Yu H, Jove R (2004). The STATs of cancer - new molecular targets come of age. Nat Rev Cancer, 4, 97-105.
23. Zhang XQ, Jia XY, Fang GY, et al (2010). p-STAT3 expression in gastric carcinoma and its significance. Modern Chin Med, 12, 1-3.